Ann Qin

602 citations
23 papers · 267 · h-index 11

Impact in

Papers in

  • Oncology 13
    • Drug Transport and Resistance Mechanisms 8
    • Cytokine Signaling Pathways and Interactions 2
  • Epidemiology 7
    • Liver Disease Diagnosis and Treatment 6
Co-authors
Justin Q. Ly (5 shared papers)Yuzhong Deng (5 shared papers)Xiaorong Liang (5 shared papers)Bianca M. Liederer (4 shared papers)Edna F. Choo (2 shared papers)Ryan Takahashi (2 shared papers)Sheerin Shahidi-Latham (2 shared papers)Peter S. Dragovich (3 shared papers)
Journals
The Journal of Clinical Pharmacology (4 papers)Bioanalysis (3 papers)Clinical and Translational Science (2 papers)Journal of Pharmaceutical Sciences (1 paper)Neoplasia (1 paper)
Partner nations
United StatesCzechiaFrance

In The Last Decade

Ann Qin

21 papers receiving 253 citations

Peers

Ann Qin
Comparison fields: 5 of 71
  • Geriatrics and Gerontology 48
  • Physiology 27
  • Pharmacology 41
  • Pharmaceutical Science 26
  • Genetics 33
Replace Emma S. Child with:
Emma S. Child United Kingdom
Kevin Yang United States
Johannes J.M. Rood Netherlands
Dirk Bernicke Germany
Tianyu Wang China
Maria A.J. van Eijndhoven Netherlands
Silpa Narayanan United States
Upasana Ray United States
Jorge Gomez‐Galeno United States
Kunkun Han China
Ann Qin relative to Emma S. Child United Kingdom Emma S. Child's profile →
Citations per field
00.5×2×4×6×8×
Emma S. Child · 1×
Citations per year

Countries citing papers authored by Ann Qin

Since Specialization
Citations

This map shows the geographic impact of Ann Qin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ann Qin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ann Qin more than expected).

Fields of papers citing papers by Ann Qin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ann Qin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ann Qin. The network helps show where Ann Qin may publish in the future.

Co-authors

The 25 scholars most cited alongside Ann Qin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Ann Qin Line = papers co-authored together Ann Qin links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 23 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Supplementation of Nicotinic Acid with NAMPT Inhibitors Results in Loss of In Vivo Efficacy in NAPRT1-Deficient Tumor Models
Neoplasia ·Thomas O’Brien, Jason Oeh, Yang Xiao, Xiaorong Liang, Alexander Vanderbilt, Ann Qin, Lulu Yang, Leslie B. Lee, Justin Q. Ly, Ely Cosino, Jennifer A. Lacap, Annie Ogasawara, Simon P. Williams, Michelle Nannini, Bianca M. Liederer, Peter K. Jackson, Peter S. Dragovich, Deepak Sampath
201347
2
Evaluation of Homogenization Techniques for the Preparation of Mouse Tissue Samples to Support Drug Discovery
Bioanalysis ·Xiaorong Liang, Savita Ubhayakar, Bianca M. Liederer, Brian Dean, Ann Qin, Sheerin Shahidi-Latham, Yuzhong Deng
201130
3
In Vitro and In Vivo Evaluation of Amorphous Solid Dispersions Generated by Different Bench-Scale Processes, Using Griseofulvin as a Model Compound
The AAPS Journal ·Po‐Chang Chiang, Yong Cui, Yingqing Ran, Joe Lubach, Kang-Jye Chou, Linda Bao, Jia Wei, Hank La, Jonathan Hau, Amy Sambrone, Ann Qin, Yuzhong Deng, Harvey Wong
201328
4
Measuring Nad + Levels in Mouse Blood and Tissue Samples Via A Surrogate Matrix Approach Using LC–MS/MS
Bioanalysis ·Xiaorong Liang, Lulu Yang, Ann Qin, Justin Q. Ly, Bianca M. Liederer, Kirsten Messick, Shuguang Ma, Mark Zak, Peter S. Dragovich, Brian J. Dean, Cornelis E. C. A. Hop, Yuzhong Deng
201425
5
Utility of CYP3A4 and PXR-CAR-CYP3A4/3A7 Transgenic Mouse Models To Assess the Magnitude of CYP3A4 Mediated Drug–Drug Interactions
Molecular Pharmaceutics ·Justin Q. Ly, Kirsten Messick, Ann Qin, Ryan Takahashi, Edna F. Choo
201721
6
The Relative Bioavailability and Effects of Food and Acid‐Reducing Agents on Filgotinib Tablets in Healthy Subjects
Clinical Pharmacology in Drug Development ·Kacey Anderson, Hao Zheng, Mona Kotecha, Jennifer Cuvin, Bob Scott, Shringi Sharma, Ann Qin, Florence Namour, Xin Yan
201916
7
Use of Transgenic Mouse Models to Understand the Oral Disposition and Drug-Drug Interaction Potential of Cobimetinib, a MEK Inhibitor
Drug Metabolism and Disposition ·Edna F. Choo, Sarah Woolsey, Kevin DeMent, Justin Q. Ly, Kirsten Messick, Ann Qin, Ryan Takahashi
201515
8
Highly selective c-Jun N-terminal kinase (JNK) 3 inhibitors with in vitro CNS-like pharmacokinetic properties II. Central core replacement
Bioorganic & Medicinal Chemistry Letters ·R. Jeffrey Neitz, Andrei W. Konradi, Hing L. Sham, Wes Zmolek, Karina Wong, Ann Qin, Colin Lorentzen, David F. Nakamura, Kevin P. Quinn, John‐Michael Sauer, Kyle Powell, Lany Ruslim, David Chéreau, Zhao Ren, John P. Anderson, Frédérique Bard, Ted Yednock, Irene Griswold‐Prenner
201114
9
Nanosuspension delivery of paclitaxel to xenograft mice can alter drug disposition and anti-tumor activity
Nanoscale Research Letters ·Po‐Chang Chiang, Stephen E. Gould, Michelle Nannini, Ann Qin, Yuzhong Deng, Alfonso Arrazate, Kimberly R. Kam, Yingqing Ran, Harvey Wong
201412
10
Lack of Drug‐Drug Interaction Between Filgotinib, a Selective JAK1 Inhibitor, and Oral Hormonal Contraceptives Levonorgestrel/Ethinyl Estradiol in Healthy Volunteers
Clinical Pharmacology in Drug Development ·Rebecca Begley, Kacey Anderson, Timothy R. Watkins, Winnie Weng, Lorraine Ampaw, Ann Qin, Brian P. Kearney, Anita Mathias
202011
11
Organic Anion Transporting Polypeptide Inhibition Dramatically Increases Plasma Exposure but not Pharmacodynamic Effect nor Inferred Hepatic Intracellular Exposure of Firsocostat
Clinical Pharmacology & Therapeutics ·Brian J. Kirby, Justin D. Lutz, Mun Sang Yue, Kimberly L. Garrison, Ann Qin, Lorraine Ampaw, Carine Beysen, Robert P. Myers, Brian P. Kearney, Anita Mathias
202010
12
Evaluation of the potential drug interactions mediated through P‐gp, OCT2, and MATE1/2K with filgotinib in healthy subjects
Clinical and Translational Science ·Chia‐Hsiang Hsueh, Kacey Anderson, Gong Shen, Chohee Yun, Ann Qin, Ahmed A. Othman
20218
13
Filgotinib, a JAK1 Inhibitor, Has No Effect on QT Interval in Healthy Subjects
Clinical Pharmacology in Drug Development ·Kacey Anderson, Yan Xin, Hao Zheng, Chohee Yun, Ellen Kwan, Ann Qin, Florence Namour, Brian P. Kearney, Anita Mathias
20197
14
THU0117 PHARMACOKINETICS AND SHORT-TERM SAFETY OF FILGOTINIB, A SELECTIVE JANUS KINASE 1 INHIBITOR, IN SUBJECTS WITH MODERATE HEPATIC IMPAIRMENT
Annals of the Rheumatic Diseases ·Kacey Anderson, Hao Zheng, Oliver F. Medzihradsky, Yizhao Li, Ann Qin, Brian P. Kearney, Anita Mathias
20196
15
Effect of Renal Impairment on the Pharmacokinetics of Firsocostat, an Acetyl‐Coenzyme A Carboxylase Inhibitor, and Cilofexor, a Selective Nonsteroidal Farnesoid X Receptor Agonist
The Journal of Clinical Pharmacology ·Elijah Weber, Islam R. Younis, Cara Nelson, Dora Ding, Ann Qin, Deqing Xiao, Timothy R. Watkins, Ahmed A. Othman
20234
16
Evaluation of the Potential for Cytochrome P450 and Transporter-Mediated Drug–Drug Interactions for Firsocostat, a Liver-Targeted Inhibitor of Acetyl-CoA Carboxylase
Clinical Pharmacokinetics ·Elijah J. Weber, Islam R. Younis, Cara Nelson, Ann Qin, Timothy R. Watkins, Ahmed A. Othman
20243
17
Plasma Protein Binding Determination for Unstable Ester Prodrugs: Remdesivir and Tenofovir Alafenamide
Journal of Pharmaceutical Sciences ·Anita Wen, Ann Qin, Thomas Tarnowski, Kah Hiing John Ling, Haeyoung Zhang, Rita Humeniuk, Sean Regan, Jovita M. Saquing, Wenbin Liu, Lata Venkatarangan, Deqing Xiao
20232
18
Pharmacokinetics and Safety of Firsocostat, an Acetyl‐Coenzyme A Carboxylase Inhibitor, in Participants with Mild, Moderate, and Severe Hepatic Impairment
The Journal of Clinical Pharmacology ·Islam R. Younis, Cara Nelson, Elijah J. Weber, Ann Qin, Timothy R. Watkins, Ahmed A. Othman
20242
19
Collagenase as an Effective Tool for Drug Quantitation in Tissues
Bioanalysis ·Ann Qin, Xiaorong Liang, Yuzhong Deng, Brian Dean, Sheerin Shahidi-Latham
20152
20
Pharmacokinetics and Safety of Cilofexor and Firsocostat in Healthy Japanese and Non‐Japanese Participants
The Journal of Clinical Pharmacology ·Islam R. Younis, Cara R. Nelson, Elijah J. Weber, Gong Shen, Ann Qin, Deqing Xiao, Timothy R. Watkins, Ahmed A. Othman
20242

About Ann Qin

Ann Qin is a scholar working on Oncology, Epidemiology, Hematology, Molecular Biology and Genetics, having authored 23 papers that have together received 267 indexed citations. Recurring topics across this work include Drug Transport and Resistance Mechanisms (8 papers), Liver Disease Diagnosis and Treatment (6 papers), Chronic Myeloid Leukemia Treatments (5 papers), Pharmacogenetics and Drug Metabolism (3 papers), Sirtuins and Resveratrol in Medicine (3 papers), Drug Solubulity and Delivery Systems (2 papers), Cytokine Signaling Pathways and Interactions (2 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (2 papers). The work is most often cited by research in Geriatrics and Gerontology (48 citations), Physiology (27 citations), Pharmacology (41 citations), Pharmaceutical Science (26 citations) and Genetics (33 citations). Ann Qin has collaborated with scholars based in United States, Czechia and France. Frequent co-authors include Justin Q. Ly, Yuzhong Deng, Xiaorong Liang, Bianca M. Liederer, Edna F. Choo, Ryan Takahashi, Sheerin Shahidi-Latham, Peter S. Dragovich, Brian Dean and Lulu Yang. Their work appears in journals such as The Journal of Clinical Pharmacology, Bioanalysis, Clinical and Translational Science, Journal of Pharmaceutical Sciences and Neoplasia.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Emma S. ChildBreakdown of academic impact, for papers by Kevin YangBreakdown of academic impact, for papers by Johannes J.M. RoodBreakdown of academic impact, for papers by Dirk BernickeBreakdown of academic impact, for papers by Tianyu WangBreakdown of academic impact, for papers by Maria A.J. van EijndhovenBreakdown of academic impact, for papers by Silpa NarayananBreakdown of academic impact, for papers by Upasana RayBreakdown of academic impact, for papers by Jorge Gomez‐GalenoBreakdown of academic impact, for papers by Kunkun Han